Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical Studies

INTRODUCTION: Individualised benefit–harm assessments can help identify patient-perceived benefits and harms of a treatment, and associated trade-offs that may influence patients’ willingness to use a treatment. This research presents the first use of a patient-reported outcome measure designed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gater, Adam, Reaney, Matthew, Findley, Amy, Brun-Strang, Catherine, Burrows, Kate, Nguyên-Pascal, My-Liên, Roborel de Climens, Aude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007419/
https://www.ncbi.nlm.nih.gov/pubmed/31679129
http://dx.doi.org/10.1007/s40264-019-00877-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007419/
https://www.ncbi.nlm.nih.gov/pubmed/31679129
http://dx.doi.org/10.1007/s40264-019-00877-4

Ejemplares similares